Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Kezar Life Sciences Closes $23M Series A Financing

June 17, 2015 1:39 pm | News | Comments

Kezar Life Sciences, a company focused on the discovery and development of drugs targeting protein homeostasis for autoimmune disorders, announced the completion of a Series A financing totaling $23 million. Read more...

TOPICS:

Seeking Rare Cells

June 17, 2015 1:33 pm | by MIT | News | Comments

Christopher Love uses microscale technology to isolate rare cells, yielding insight into human disease. Read more...

TOPICS:

Johns Hopkins University, Bayer to Develop New Ophthalmic Therapies

June 17, 2015 1:03 pm | by Johns Hopkins University | News | Comments

The Johns Hopkins University and Bayer HealthCare have entered into a five-year collaboration agreement to jointly develop new ophthalmic therapies targeting retinal diseases. The goal of the strategic research alliance is to accelerate the translation of innovative approaches from the laboratory to the clinic, ultimately offering patients new treatment options for several retinal diseases. Read more...

TOPICS:
Advertisement

Bert Vogelstein, M.D., Wins 2015 Dr. Paul Janssen Award for Biomedical Research

June 17, 2015 12:58 pm | News | Comments

Johnson & Johnson today named Dr. Bert Vogelstein of Johns Hopkins University, Johns Hopkins Kimmel Cancer Center and the Howard Hughes Medical Institute, the winner of the 2015 Dr. Paul Janssen Award for Biomedical Research for his breakthroughs in oncology research, which have spanned more than two decades and have formed the basis of modern cancer research. Read more...

TOPICS:

Complex, Large-scale Genome Analysis Made Easier

June 17, 2015 12:51 pm | by European Molecular Biology Laboratory | News | Comments

Researchers at EMBL-EBI have developed a new approach to studying the effect of multiple genetic variations on different traits. The new algorithm,published in Nature Methods, makes it possible to perform genetic analysis of up to 500,000 individuals — and many traits at the same time. Read more...

TOPICS:

The Rise of Syngeneic Models in Cancer Immunotherapy

June 17, 2015 10:06 am | by Sheri Barnes, Ph.D., Study Director, Charles River | Articles | Comments

With cancer immunotherapy a major focus of oncology research over the past several years, a blockbuster drug will likely target the immune system. The industry is responding in kind by developing new tools that can be employed in this rapidly expanding field. One tool oncology researchers are exploring is actually not new at all—the murine tumor model. Read more...

TOPICS:

'Core' Immune Cells Reduce Symptoms, Spread of Seasonal and Pandemic Influenza

June 17, 2015 9:16 am | by University of Oxford | News | Comments

Influenza A is the most common type of influenza and is the only type that can cause pandemics. Read more...

TOPICS:

Big Shareholder Backs Drugmaker Mylan's Growth Strategy

June 17, 2015 9:08 am | by The Associated Press | News | Comments

Mylan's largest shareholder has backed the generic drugmaker's plan to remain a stand-alone company as it fights a takeover bid from larger rival Teva Pharmaceutical. Read more...

TOPICS:
Advertisement

Allergan to Acquire Kythera Biopharmaceuticals

June 17, 2015 8:53 am | News | Comments

This purchase compliments Allergan's existing position in facial aesthetics. Read more...

TOPICS:

Richter, Allergan Announce FDA Extended Review Period for Cariprazine to September 2015

June 17, 2015 8:47 am | News | Comments

Cariprazine is being reviewed for the treatment of schizophrenia and for the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults. Read more...

TOPICS:

UN: Spread of MERS in South Korea Isn't Global Emergency

June 17, 2015 8:42 am | by Maria Cheng, AP Medical Writer | News | Comments

WHO acknowledged there were still fundamental gaps in its understanding of the disease nearly three years after MERS was first identified. Read more...

TOPICS:

Oramed Granted Patent in Russia for Oral Administration of GLP-1

June 17, 2015 8:38 am | News | Comments

GLP-1 is an incretin hormone that stimulates the secretion of insulin from the pancreas. Read more...

TOPICS:

Antibiotics Not Given Same Research Attention as Rare Diseases, Says Report

June 16, 2015 1:12 pm | by Stephanie Guzowski, Editor | News | Comments

In a report that highlights the striking difference between research into rare diseases, vaccines and antibiotics across the globe, there exists a major concern: the antibiotics market is at “risk of losing another decade to inadequate levels of research and innovations,” according to a new report, released today at the BIO International Convention 2015 in Philadelphia. Read more...

TOPICS:

Breakthrough Points to Cure for Debilitating Heart and Lung Disease

June 16, 2015 11:01 am | by University of Lincoln | News | Comments

A protein that targets the effects of a faulty gene could offer the first treatment targeting the major genetic cause of Pulmonary Arterial Hypertension (PAH), according to research funded by the British Heart Foundation (BHF). Read more....

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading